Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002962 (
angina
)
21,142
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The changes of the plasma zinc, copper and erythrocyte glutathione peroxidase (GSH-Px) were measured by atomic absorption spectrometry and
DTNB
color development, in 31 patients suffering from coronary heart disease with
angina
Pectoris before and after taking Kuo-Guan granule one month. The results showed the plasma zinc was 16.83 +/- 2.60 mumol/L, copper 14.17 +/- 2.99 mumol/L, and erythrocyte GSH-Px 0.75 +/- 0.12 Eu/Hbmg/min in the normal control group. In patients with
angina
Pectoris, the plasma zinc was 14.39 +/- 4.44 mumol/L, copper 17.47 +/- 4.42 mumol/L, and erythrocyte GSH-Px 0.49 +/- 0.075 Eu/Hbmg/min before treatment; the plasma zinc was 20.17 +/- 3.97 mumol/L, copper 15.74 +/- 3.15 mumol/L, and erythrocyte GSH-Px 0.72 +/- 0.10 Eu/Hbmg/min after treatment. These results indicate that the plasma zinc and erythrocyte GSH-Px were lower and copper was higher in the patients than the normal control group before treatment (P less than 0.01), the plasma zinc and erythrocyte GSH-Px were increased and copper was decreased after treatment (P less than 0.01). These suggest that therapeutic mechanism of Kuo-Guan granule to coronary heart disease with
angina
Pectoris may be related to it's regulation on trace elements disturbance in body.
...
PMID:[Effects of kuo-guan granule on plasma zinc, copper and erythrocyte GSH-Px (glutathione peroxidase) in patients with angina pectoris]. 239 54